COLLEGIUM PHARMACEUTICAL, INC (COLL) › Cash & EquivalentsCOLLEGIUM PHARMACEUTICAL, INC (COLL) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2012: $11.94M2013: $7.55M2014: $1.63M2015: $95.70M2016: $153.22M2017: $118.70M2018: $146.63M2019: $170.02M2020: $174.12M2021: $186.43M2022: $173.69M2023: $238.95M2024: $70.56M2025: $231.25M$231.25M2012Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$231.25M+227.7%2024$70.56M-70.5%2023$238.95M+37.6%2022$173.69M-6.8%2021$186.43M+7.1%2020$174.12M+2.4%2019$170.02M+15.9%2018$146.63M+23.5%2017$118.70M-22.5%2016$153.22M+60.1%2015$95.70M+5756.6%2014$1.63M-78.4%2013$7.55M-36.7%2012$11.94M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share